Effect of Wheat Dextrin on Calcium and Magnesium Absorption
Benefiber
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
To compare calcium and magnesium absorption within subjects with and without chronic consumption of wheat dextrin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Oct 2009
Shorter than P25 for phase_4
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 28, 2010
CompletedFirst Posted
Study publicly available on registry
October 29, 2010
CompletedOctober 29, 2010
October 1, 2010
8 months
October 28, 2010
October 28, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Calcium Absorption
The calcium load to be tested will be 300 mg calcium from calcium and vitamin D fortified TropicanaTM orange juice extrinsically labeled with ≈3-7 μCi of 45Ca. The labeled orange juice will be ingested as part of a light meal, served as breakfast, after an overnight fast.
within 2-4 weeks
Secondary Outcomes (1)
Magnesium absorption
within 2-4 weeks
Study Arms (2)
placebo
PLACEBO COMPARATORControl cookies will contain no wheat dextrin and will be taken 3 times daily for 2 weeks.
wheat dextrin
EXPERIMENTALwheat dextrin (formulated according to the supporter's established method), will be baked in cookies providing three doses per day (≈5 gram of wheat dextrin in each dose)for 2 weeks.
Interventions
5 grams of wheat dextrin baked in cookies will be taken 3 times a day for 2 weeks
cookies not containing wheat dextrin will be taken 3 times a day for 2 weeks
Eligibility Criteria
You may qualify if:
- \- Subjects will be generally healthy Caucasian females aged 19 and older with no known abnormalities of gastrointestinal function, and taking no medications that might alter absorptive performance. BMI will be between 19 and 31 kg/m2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Creighton Universitylead
- Novartiscollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laura Armas, MD
Creighton University
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 28, 2010
First Posted
October 29, 2010
Study Start
October 1, 2009
Primary Completion
June 1, 2010
Study Completion
October 1, 2010
Last Updated
October 29, 2010
Record last verified: 2010-10